longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DNTH

DNTH
----

LongbridgeAI

Dianthus Therapeutics SVP General Counsel Adam Veness melepas saham senilai USD 2,21 juta

PUBT
Aug 11, 2026 at 09:09 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Adam M. Veness, SVP General Counsel of Dianthus Therapeutics, sold all his common stock holdings. He executed sales of 20,000 shares on August 7 and 10, 2026, at an average weighted price of approximately USD 110.63 per share, reducing his ownership to zero.

  • SVP, General Counsel dan Secretary Adam M Veness melepas seluruh kepemilikan saham biasa Dianthus Therapeutics. * Ia mengeksekusi 20.000 saham pada USD 17,88 pada 7 Agustus dan 10 Agustus 2026. * Ia menjual 20.000 saham pada harga rata-rata tertimbang sekitar USD 110,63 per saham, sehingga kepemilikan saham menjadi nol. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001778623-26-000007), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Login to unlock556characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Dianthus Therapeutics

Dianthus Therapeutics

DNTH.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--